Enveda Raises $311M to Advance Ai-driven Natural Drug Development

WHO:

Techmeme - Enveda is a Colorado-based biotech startup that uses AI to discover new drugs in the natural world.

WHAT:

Techmeme - Enveda raised $311 million in a Series E funding round.

TechCrunch - The funding round valued Enveda at $2 billion, which is double its valuation from the previous year.

TechCrunch - Enveda is currently testing drugs that treat skin conditions and help preserve weight loss after stopping GLP-1 medications.

WHERE:

Techmeme - Enveda is based in Colorado.

WHEN:

Techmeme - The Series E funding round occurred recently, but no specific date is provided.

WHY:

TechCrunch - The funding aims to advance the development of nature-derived AI drugs into clinical trials.

HOW:

Techmeme - Enveda utilizes AI technology to discover new drugs from natural sources.

(UPDATED September 23, 2026 23:01 UTC)

Enveda, a Colorado-based biotech startup, has successfully raised $311 million in a Series E funding round, bringing its valuation to $2 billion, which is double what it was just a year ago. The company is currently focused on developing AI-driven drugs that treat skin conditions and help maintain weight loss after the discontinuation of GLP-1 medications. This funding will support Enveda's efforts to advance these nature-derived drugs into clinical trials.